Cette recherche s'applique uniquement aux ressources en bibliothèque.
32 résultats
Trier par:
Ajouter à la liste:
    • Article
    Sélectionner

    The Adoption of Secondary Legislation through Comitology in the EU: Some Reflections on the Regulation (EU) 182/2011 in Comparison with the Pre-Lisbon Reform

    Corona, Daniela
    Theory and practice of legislation (Oxford, England), 01 July 2014, Vol.2(1), pp.85-107 [Revue évaluée par les pairs]
    Taylor & Francis (Taylor & Francis Group)
    Disponible
    Plus…
    Titre: The Adoption of Secondary Legislation through Comitology in the EU: Some Reflections on the Regulation (EU) 182/2011 in Comparison with the Pre-Lisbon Reform
    Auteur: Corona, Daniela
    Sujet: Comitology ; Regulation (Eu) 182/2011 ; Lisbon Treaty ; European Commission ; European Parliament ; Council ; Appeal Committee ; Balance of Powers ; Transparency ; Orphacol ; Gmos ; Law
    Description: The Lisbon Treaty reform provided an important innovation in the EU regulatory activity by differentiating between the legislative delegation (art. 290 TFEU) and the executive delegation (art. 291 TFEU). In so doing, the central role of the European Commission in the Comitology procedures as well as the power of the European Parliament and the Council to control its executive powers have been modified. The new 2011 Comitology Regulation aimed at creating a more intelligible and transparent committees' system where the EC is expected to act in a stricter framework. The paper argues that the new Regulation preserves the efficiency of the Comitology system; at the same time, however, it does not really improve the level of transparency and clarity in the way in which the committees' procedures works. Moreover, as the practice clearly shows, the EC continues to enjoy a broad discretion in the adoption of implementing acts.
    Fait partie de: Theory and practice of legislation (Oxford, England), 01 July 2014, Vol.2(1), pp.85-107
    Identifiant: 2050-8840 (ISSN); 2050-8859 (E-ISSN); 10.5235/2050-8840.2.1.85 (DOI)

    • Livre
    Sélectionner

    Il multilinguismo : aspetti letterari, linguistici e culturali

    Corona, Daniela
    Palermo : Flaccovio
    2002
    Recherche de la disponibilité
    Plus…
    Chargement
    Erreur de chargement
    Titre: Il multilinguismo : aspetti letterari, linguistici e culturali / a cura di Daniela Corona e Giuliana Costa Ragusa
    Auteur: Corona, Daniela
    Editeur: Palermo : Flaccovio
    Date: 2002
    Collation: 140 p. ; 21cm
    Collection: Lingua e testo ; 1
    Documents dans cette collection: Lingua e testo
    Sujet RERO: Multilinguisme
    Classification: eti1 306.446
    eti2 306.446 COR
    Identifiant: 8878042676 (ISBN)
    No RERO: R003860912
    Permalien:
    http://data.rero.ch/01-R003860912/html?view=GE_V1

    • Plusieurs versions

    Impact of Conversion to a Once Daily Tacrolimus-Based Regimen in Kidney Transplant Recipients With Gastrointestinal Complications

    Veroux, Massimiliano, Grosso, Giuseppe, Ekser, Burcin, Corona, Daniela, Giaquinta, Alessia, Veroux, Pierfrancesco
    Transplantation Journal, 2012, Vol.93(9), pp.895-899 [Revue évaluée par les pairs]

    • Plusieurs versions

    Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease

    Veroux, Massimiliano, Gozzo, Cecilia, Corona, Daniela, Murabito, Paolo, Caltabiano, Daniele Carmelo, Mammino, Luca, Giaquinta, Alessia, Zerbo, Domenico, Sinagra, Nunziata, Veroux, Pierfrancesco, Palmucci, Stefano
    PLoS ONE, 2018, Vol.13(12) [Revue évaluée par les pairs]

    • Plusieurs versions

    Pregnancy under everolimus‐based immunosuppression

    Veroux, Massimiliano, Corona, Daniela, Veroux, Pierfrancesco
    Transplant International, December 2011, Vol.24(12), pp.e115-e117 [Revue évaluée par les pairs]

    • Plusieurs versions

    Exploring new frontiers: sirolimus as a pharmacokinetic modulator in advanced cancer patients

    Veroux, Massimiliano, Tallarita, Tiziano, Corona, Daniela, D'Assoro, Antonino, Veroux, Pierfrancesco
    Expert review of anticancer therapy, 01 January 2013, Vol.13(1), pp.17-20 [Revue évaluée par les pairs]

    • Plusieurs versions

    Age is an important predictor of kidney transplantation outcome

    Veroux, Massimiliano, Grosso, Giuseppe, Corona, Daniela, Mistretta, Antonio, Giaquinta, Alessia, Giuffrida, Giuseppe, Sinagra, Nunzia, Veroux, Pierfrancesco
    Nephrology Dialysis Transplantation, 2012, Vol. 27(4), pp.1663-1671 [Revue évaluée par les pairs]

    • Article
    Sélectionner

    Rare cause of odynophagia: Giant esophageal ulcer

    Veroux, Massimiliano, Aprile, Giuseppe, Amore, Francesca F, Corona, Daniela, Giaquinta, Alessia, Veroux, Pierfrancesco
    World journal of gastroenterology, 14 April 2016, Vol.22(14), pp.3875-8 [Revue évaluée par les pairs]
    MEDLINE/PubMed (U.S. National Library of Medicine)
    Disponible
    Plus…
    Titre: Rare cause of odynophagia: Giant esophageal ulcer
    Auteur: Veroux, Massimiliano; Aprile, Giuseppe; Amore, Francesca F; Corona, Daniela; Giaquinta, Alessia; Veroux, Pierfrancesco
    Sujet: Acyclovir ; Endoscopy ; Gastrointestinal Complications ; Idiopathic ; Kidney Transplantation ; Steroid ; Immunocompromised Host ; Deglutition Disorders -- Immunology ; Esophageal Diseases -- Immunology ; Immunosuppressive Agents -- Adverse Effects ; Kidney Transplantation -- Adverse Effects ; Ulcer -- Immunology
    Description: Gastrointestinal complications are a frequent cause of morbidity after transplantation and may affect up to 40% of kidney transplant recipients. Here we report a rare case of idiopathic giant esophageal ulcer in a kidney transplant recipient. A 37-year-old female presented with a one-week history of odynophagia and weight loss. Upon admission, the patient presented cold sores, and a quantitative cytomegalovirus polymerase chain reaction was positive (10(5) copies/mL). An upper endoscopy demonstrated the presence of a giant ulcer. Serological test and tissue biopsies were unable to demonstrate an infectious origin of the ulcer. Immunosuppression was reduced and everolimus was introduced. An empirical i.v. therapy with acyclovir was started, resulting in a dramatic improvement in symptoms and complete healing of the ulcer. Only two cases of idiopathic giant esophageal ulcer in kidney transplant recipients have been reported in the literature; in both cases, steroid therapy was successful...
    Fait partie de: World journal of gastroenterology, 14 April 2016, Vol.22(14), pp.3875-8
    Identifiant: 2219-2840 (E-ISSN); 27076774 Version (PMID); 10.3748/wjg.v22.i14.3875 (DOI)

    • Article
    Sélectionner

    Sirolimus in solid organ transplantation: current therapies and new frontiers

    Veroux, Massimiliano, Tallarita, Tiziano, Corona, Daniela, D'Assoro, Antonino, Gurrieri, Carmelina, Veroux, Pierfrancesco
    Immunotherapy, December 2011, Vol.3(12), pp.1487-97 [Revue évaluée par les pairs]
    MEDLINE/PubMed (U.S. National Library of Medicine)
    Disponible
    Plus…
    Titre: Sirolimus in solid organ transplantation: current therapies and new frontiers
    Auteur: Veroux, Massimiliano; Tallarita, Tiziano; Corona, Daniela; D'Assoro, Antonino; Gurrieri, Carmelina; Veroux, Pierfrancesco
    Sujet: Organ Transplantation ; Graft Rejection -- Immunology ; Sirolimus -- Therapeutic Use
    Description: Sirolimus (SRL) is a mammalian target of rapamycin inhibitor, which provides an immunosuppressive effect by inhibiting cell cycle progression. The encouraging results of combined SRL-cyclosporine therapy paved the way to further immunosuppressant combinations. Although SRL is relatively non-nephrotoxic when administered as monotherapy, it pharmacodynamically enhances the toxicity of calcineurin inhibitors. Other side effects may include hyperlipidemia and myelosuppression and less commonly wound healing impairment, proteinuria, edema and pneumonitis. Surprisingly, SRL also showed encouraging properties as an antiatherogenic and antineoplastic, opening a large spectrum of new potential applications. Whether SRL can be used safely over the long term with low doses of calcineurin inhibitors requires further study. The use of SRL as a corticosteroid-sparing agent also remains to be proven in controlled trials.
    Fait partie de: Immunotherapy, December 2011, Vol.3(12), pp.1487-97
    Identifiant: 1750-7448 (E-ISSN); 22091684 Version (PMID); 10.2217/imt.11.143 (DOI)

    • Plusieurs versions

    Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation

    Veroux, Massimiliano, Tallarita, Tiziano, Corona, Daniela, Sinagra, Nunziata, Giaquinta, Alessia, Zerbo, Domenico, Guerrieri, Carmela, D'Assoro, Antonino, Cimino, Sebastiano, Veroux, Pierfrancesco
    Clinical and Developmental Immunology, 2013, Vol.2013, 7 pages [Revue évaluée par les pairs]